| Primary |
| Induction Of Anaesthesia |
16.0% |
| Pain |
16.0% |
| Analgesic Therapy |
8.0% |
| Chills |
8.0% |
| General Anaesthesia |
8.0% |
| Hypertension |
8.0% |
| Abdominal Pain |
4.0% |
| Complex Regional Pain Syndrome |
4.0% |
| Depression |
4.0% |
| Drug Therapy |
4.0% |
| Drug Use For Unknown Indication |
4.0% |
| Maintenance Of Anaesthesia |
4.0% |
| Pancreatitis Acute |
4.0% |
| Premedication |
4.0% |
| Procedural Pain |
4.0% |
|
| Drug Hypersensitivity |
19.0% |
| Unresponsive To Stimuli |
14.3% |
| Completed Suicide |
9.5% |
| Death |
9.5% |
| Grand Mal Convulsion |
9.5% |
| Serotonin Syndrome |
9.5% |
| Drug Tolerance Increased |
4.8% |
| Exposure During Pregnancy |
4.8% |
| Medication Error |
4.8% |
| Muscle Spasms |
4.8% |
| Tachycardia |
4.8% |
| Urinary Incontinence |
4.8% |
|
| Secondary |
| Product Used For Unknown Indication |
38.2% |
| Drug Use For Unknown Indication |
18.4% |
| Pain |
15.2% |
| Foetal Exposure During Pregnancy |
9.2% |
| Convulsion |
1.8% |
| Depression |
1.8% |
| Burning Sensation |
1.4% |
| Endoscopy |
1.4% |
| Migraine |
1.4% |
| Pancreatitis Acute |
1.4% |
| Sedation |
1.4% |
| Anxiety |
0.9% |
| Asthma |
0.9% |
| Culture Positive |
0.9% |
| Gastric Ulcer |
0.9% |
| Hypertension |
0.9% |
| Induction Of Anaesthesia |
0.9% |
| Light Anaesthesia |
0.9% |
| Musculoskeletal Stiffness |
0.9% |
| Type 2 Diabetes Mellitus |
0.9% |
|
| Drug Hypersensitivity |
16.4% |
| Respiratory Arrest |
14.5% |
| Toxicity To Various Agents |
10.9% |
| Drug Abuse |
9.1% |
| Poisoning |
7.3% |
| Drug Toxicity |
5.5% |
| Somnolence |
5.5% |
| Cardio-respiratory Arrest |
3.6% |
| Completed Suicide |
3.6% |
| Unresponsive To Stimuli |
3.6% |
| Vomiting |
3.6% |
| Accidental Overdose |
1.8% |
| Cardiac Arrest |
1.8% |
| Death |
1.8% |
| Drug Ineffective |
1.8% |
| Drug Tolerance |
1.8% |
| Erythema |
1.8% |
| Exposure During Pregnancy |
1.8% |
| Intentional Drug Misuse |
1.8% |
| Lower Limb Fracture |
1.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
40.0% |
| Drug Use For Unknown Indication |
19.9% |
| Pain |
10.2% |
| Mantle Cell Lymphoma |
2.5% |
| Anticoagulant Therapy |
2.3% |
| Anxiety |
2.1% |
| Prophylaxis |
2.1% |
| Adverse Event |
1.9% |
| Drug Exposure During Pregnancy |
1.9% |
| Nausea |
1.9% |
| Contraception |
1.7% |
| Coronary Artery Bypass |
1.7% |
| Hypertension |
1.7% |
| Premedication |
1.7% |
| Antifungal Prophylaxis |
1.5% |
| Antiviral Prophylaxis |
1.5% |
| Chronic Lymphocytic Leukaemia |
1.5% |
| Depression |
1.5% |
| Constipation |
1.3% |
| Infusion Related Reaction |
1.1% |
|
| Pulmonary Embolism |
18.9% |
| Deep Vein Thrombosis |
9.4% |
| Thrombocytopenia |
9.4% |
| Pain |
7.5% |
| Death |
5.7% |
| Vaginal Haemorrhage |
5.7% |
| Weight Increased |
5.7% |
| Haemorrhage |
3.8% |
| Pneumonia |
3.8% |
| Psychiatric Symptom |
3.8% |
| Type 2 Diabetes Mellitus |
3.8% |
| Urinary Tract Infection |
3.8% |
| Vomiting |
3.8% |
| White Blood Cell Count Decreased |
3.8% |
| Abdominal Pain Lower |
1.9% |
| Abdominal Pain Upper |
1.9% |
| Abscess |
1.9% |
| Angioedema |
1.9% |
| Anhedonia |
1.9% |
| Anxiety |
1.9% |
|
